Skip to main content
Gagan Singh, MD, Cardiology, Sacramento, CA

GaganDSinghMDM.S.

Cardiology Sacramento, CA

Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Vascular Medicine, Cardiac Critical Care

Physician

Dr. Singh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Singh's full profile

Already have an account?

  • Office

    4860 Y St
    Suite 2820
    Sacramento, CA 95817
    Phone+1 916-734-3764

Education & Training

  • University of California Davis Health
    University of California Davis HealthFellowship, Interventional Cardiology, 2014 - 2016
  • University of California Davis Health
    University of California Davis HealthFellowship, Cardiovascular Disease, 2011 - 2014
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2008 - 2011
  • New York Medical College
    New York Medical CollegeClass of 2008
  • New York Medical College
    New York Medical CollegeM.S., Physiology, 2004
  • Manhattanville College
    Manhattanville CollegeB.A., Biology with concentration in Neuroscience, Departmental Honors, 1997 - 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - 2026
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • First Place, C3 Annual Summit for Interventional Fellows-in-Training, SCAI Scientific Sessions Society for Cardiovascular Angiography and Interventions, 2015
  • Trainee Research Award, Department of Internal Medicine University of California (Davis) Medical Center, 2014
  • Finalist, Best Cases of the Year, Trans-Valvular Therapeutics (TVT) 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Epidemiology, Clinical Manifestations, and Management of Chagas Heart Disease  
    Malik LH, Singh GD, and Amsterdam EA, Clin Cardiol, 1/21/2015
  • Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical...  
    Armstrong EJ, Chen DC, Singh GD, Amsterdam EA, and Laird JR, Vascular Medicine, 1/1/2015
  • Adherence to guideline recommended therapies among patient’s with diverse manifestations of vascular disease  
    Chen DC, Armstrong EJ, Singh GD, Amsterdam EA, Laird JR, Vasc Health Risk Manag, 1/1/2015
  • Join now to see all

Books/Book Chapters

Lectures

  • A Novel Robotic Catheter for Precise and Reproducible Delivery of Transcatheter Devices for Structural Heart Interventions 
    CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019
  • Successful Case in Complex Anatomy 
    CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
  • A Novel Robotic Catheter for Precise and Reproducible Delivery of Transcatheter Devices for SHD Interventions 
    CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/12/2019
  • Join now to see all

Press Mentions

  • Adona Medical Initiates First-in-Human Study with Its Novel Interatrial Shunt for Patients with Heart Failure
    Adona Medical Initiates First-in-Human Study with Its Novel Interatrial Shunt for Patients with Heart FailureOctober 27th, 2024
  • Heart Team Performs First Transfemoral Transseptal Mitral Valve Replacement Procedure
    Heart Team Performs First Transfemoral Transseptal Mitral Valve Replacement ProcedureJanuary 13th, 2023
  • Supira Medical Announces Successful First-in-Human Use of Its Next Generation Percutaneous Ventricular Assist Device
    Supira Medical Announces Successful First-in-Human Use of Its Next Generation Percutaneous Ventricular Assist DeviceSeptember 19th, 2022
  • Join now to see all

Professional Memberships